CSCs are also called TICs, because when inoculated into severe combined immunodeficiency disease (SCID) mice, represent the minority of breast cancer cells capable of forming new tumours and are CD44+/CD24–/low/lineage–4. This evidence concerns the gene CD24 and breast carcinoma.